Wetherby Asset Management Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Wetherby Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $3,752 - $5,911	3,540 Added 31.53%	14,768 $17,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $4,648 - $6,603	-3,689 Reduced 24.73%	11,228 $18,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $1,291 - $2,037	802 Added 5.68%	14,917 $26,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $8,522 - $14,578	-7,476 Reduced 34.63%	14,115 $26,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $10,896 - $19,885	-9,080 Reduced 29.6%	21,591 $28,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $49,993 - $107,961	30,671 New	30,671 $51,000

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.